Hengyuehe Biopharma News

You are here: Home > News > Company News

Featured Topics

Connecting the World, Innovating in Pharmaceuticals – The official website of Shanghai Hengyuehe Biopharmaceutical Co., Ltd. has been successfully launched.

Connecting the World, Innovating in Pharmaceuticals – The official website of Shanghai Hengyuehe Biopharmaceutical Co., Ltd. has been successfully launched.

The official website of Shanghai Hengyuehe Biopharmaceutical Co., Ltd. is now live! We specialize in the R&D and manufacturing of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), pharmaceutical excipients, and high-end chemical products, and offer customized CDMO services. GMP-compliant production base, the trusted partner of 120 pharmaceutical companies.

Company News
Heng Yue He Appears at CPHI China 2026, One-Stop CDMO Service Attracts Global Merchants to Stop

Heng Yue He Appears at CPHI China 2026, One-Stop CDMO Service Attracts Global Merchants to Stop

Hengyuehe made its debut at CPHI China 2026, with its one-stop CDMO services drawing global visitors to stop by and engage in discussions. The company showcased its comprehensive R&D and manufacturing capabilities in pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and high-end specialty chemicals, reached preliminary cooperation agreements with pharmaceutical companies in multiple countries, and continued to deepen its global footprint.

Hengyue Wo's official website is newly launched, enabling a new journey of pharmaceutical research and development.

Hengyue Wo's official website is newly launched, enabling a new journey of pharmaceutical research and development.

Shanghai Hengyue Heo Biomedical Co., Ltd. was established in 2010 and is headquartered in Shanghai. It is a high-tech enterprise integrating R & D, production and sales. Our core business spans pharmaceutical intermediates, active pharmaceutical ingredients (APIs), pharmaceutical excipients, and high-end specialty chemicals, and we are committed to providing the global pharmaceutical industry with high-quality, high-standard raw materials and customized CDMO services. The company operates multip